openPR Logo
Press release

Leiber GmbH expands international aquaculture business relationship

05-13-2014 06:40 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Leiber GmbH

Leiber GmbH expands international aquaculture business

By signing the distribution contract between Leiber GmbH and the company PHARMAQ AS, headquartered in Norway, Leiber GmbH teams up with a further distribution partner in the growing markets of aquaculture and expands its existing business activities.

PHARMAQ AS develops, produces and markets vaccines and health products for the global fish farming industry. Their customers are found in the salmonid, tilapia, pangasius, sea bass and bream segments. “Pharmaq provides an excellent platform to extend a broad network in the continuously growing market of the aquaculture industry”, Nicolaus Jungbluth, Business Unit Director Animal Nutrition at Leiber GmbH, appreciates the partnership. He also adds: “PHARMAQ brings an outstanding competence in the field of fish health and fish immunology. Through the cooperation we are able to exchange further important experiences in this field and assure both parties’ positions in the market.

For 60 years, Leiber GmbH, located in Bramsche in Lower Saxony, has been one of the leading manufacturers of specialist yeast products “made in Germany”. The natural raw material brewers’ yeast is processed using an innovative biotechnological method to form high-quality products which are used in the areas of animal nutrition, food, food supplements and biotechnology. With two locations in Lower Saxony, as well as further production sites in Poland and Russia, Leiber manufactures brewers’ yeast products and yeast extracts of the highest quality with over 170 committed members of staff.

Leiber GmbH
Hafenstraße 24
49565 Bramsche
Telefon: +49 (0) 5461 / 9303-0
Telefax: +49 (0) 5461 / 9303-28
E-Mail: info@leibergmbh.de
www.leibergmbh.de

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Leiber GmbH expands international aquaculture business relationship here

News-ID: 287334 • Views:

More Releases from Leiber GmbH

Leiber animal nutrition – Gold medal and innovation prize in Poland
Leiber animal nutrition – Gold medal and innovation prize in Poland
This year's visit to the FERMA trade fair was crowned with shining success for Leiber GmbH and its Polish daughter company - Leiber Sp. z. o.o. based in Krosniewice. This year, the animal feed department with its brewers' yeast range was, once again, represented at the fair in Lodz. FERMA is regarded as the international trade fair and platform for producers and breeders of livestock, pork and poultry in Poland.
Leiber YeaFi® – The Yeast Fibre Concept!
Leiber YeaFi® – The Yeast Fibre Concept!
Leiber GmbH has expanded its product range in the area of combined yeast products and adjusted their feed to meet current market trends. For more than 60 years now, Leiber has been combining pure brewers’ yeast with functional fibre products such as brewers’ grains, malt sprouts or wheat germ in a manufacturing process they developed themselves to protect the nutritional ingredients in brewers’ yeast. For several years, the demand for
Leiber GmbH further invests in R&D
Leiber GmbH further invests in R&D
Since February 2016, Leiber GmbH has been reinforced by Dr med vet Claudia Westfahl - a veterinarian specialized in animal nutrition - as part of the company's strategy to invest in new product developments. With the new position ‘Product Development Animal Nutrition’, Dr Westfahl is responsible for new product development in the field of functional feed ingredients for both pet as well as farm animals. After graduating at the University
Leiber Subsidiary in Poland receives FSSC 22000 Certification
Leiber Subsidiary in Poland receives FSSC 22000 Certification
Leiber Sp. z o.o., the Polish subsidiary of Leiber GmbH, has successfully completed the FSSC 22000 Food Safety System Certification process. FSSC 22000, which is recognised internationally and also by the Global Food Safety Initiative (GFSI), was developed on the basis of the ISO 22000 Standard to define basic requirements for the certification of production processes within the food supply chain. Brewer’s yeast products are manufactured for the foodstuffs and

All 4 Releases


More Releases for PHARMAQ

Fish Vaccine Market Is Booming Worldwide | PHARMAQ, Anicon Labor GmbH, MSD Anima …
Fish Vaccine Market: The extensive research on Fish Vaccine Market, by Qurate Research is a clear representation on all the essential factors that are expected to drive the market considerably. Thorough study on Fish Vaccine Market helps the buyers of the report, customers, the stakeholders, business owners, and stockholders to understand the market in detail. The updated research report comprises key information on the market, such as market rate, estimated
Aquaculture Vaccines Market is expected to grow at a CAGR of 9.4% during 2020-20 …
The research report "Aquaculture Vaccines Market by vaccine type (Inactivated vaccine, attenuated live vaccine, DNA vaccine, and others), by application (bacterial Infection, viral Infection, combined bacterial and viral Infections, and others), by route of administration (Immersion vaccines, Injection vaccines, and oral vaccines), by species (salmon, seabass and seabream, tilapia, trout, turbot, and carp) and geography – global/region/country forecast to 2026." Glance our 200 slides market research and competitive intelligence research report,
Global Coccidiosis Treatment Market 2020 Albon, Marquis, Kyowa Hakko Bio Co, Bay …
Coccidiosis Treatment Market Global and outlook (2015 - 2025) The report published on Coccidiosis Treatment is a invaluable foundation of insightful data helpful for the decision-makers to form the business strategies related R&D investment, sales and growth, key trends, technological advancement, emerging market and more. The global Coccidiosis Treatment market report includes key facts and figures data which helps its users to understand current scenario of the global market along
Aquaculture Vaccines Market Analysis by Top Players, Region, Type, End user, Mar …
Aquaculture Vaccines Market 2019-2024: The global aquaculture vaccines market estimated to be valued US$ XX Mn in 2017 and poised to grow at significant CAGR of 19% over 2018-2025 due to surge in the of prevalence of bacterial and viral infections among aquaculture species, increase in aquaculture production around the globe, and rise in adoption of vaccines by aquaculture farmers. Aquaculture Vaccines Market Drvien by Increase in the Prevalence of Aquaculture
Aquaculture Vaccines Market: Snapshot Analysis by Top Vendors (Pharmaq AS Norway …
Global Aquaculture Vaccines Market 2019-2024: The global aquaculture vaccines market estimated to be valued US$ XX Mn in 2017 and poised to grow at significant CAGR over 2018-2025 due to surge in the of prevalence of bacterial and viral infections among aquaculture species, increase in aquaculture production around the globe, and rise in adoption of vaccines by aquaculture farmers. Key players profiled in the global aquaculture vaccines market include: • Pharmaq AS (Zoetis,
Global Aquaculture Vaccines Market By Vaccine Type, Application, Route of Admini …
Global Aquaculture Vaccines Market By Vaccine Type, Application, Route of Administration, Species and Region. Top Key players are Zoetis, LLC) Merck & Co., Inc. Virbac S.A. and Tecnovax SA. The global aquaculture vaccines market was valued around US$ XX Mn in 2017 and growing at a significant CAGR over eight years forecast period 2018-2025 Precision Business Insights (PBI) in its report titled “Global aquaculture vaccines market: Market Estimation, Dynamics, Regional